News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
$3.7 Billion Market for Parkinson’s Drugs Could Prove Key to Rainbow BioSciences, LLC’s Growth
March 6, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NOKOMIS, Fla.--(BUSINESS WIRE)--As demand for effective diagnostics and treatments for Parkinson’s Disease grows around the globe, Rainbow BioSciences (OTCBB: RBCC) is working to capitalize by helping to deliver promising new therapies to market.
Twitter
LinkedIn
Facebook
Email
Print